# WELTRUZA
> **NDA219007** · New Drug Application · Sponsor: TEVA NEUROSCIENCE INC · Approved 2026-10-08
## Drug
- **FDA Application Number:** NDA219007
- **Application type:** New Drug Application
- **Brand name:** WELTRUZA
- **Generic name:** Olanzapine
- **Active ingredients:** OLANZAPINE
- **Dosage form:** SUSPENSION, EXTENDED RELEASE
- **Route:** INJECTABLE
- **Marketing status:** Prescription
- **Sponsor:** TEVA NEUROSCIENCE INC
- **First approval:** 2026-10-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219007)
---
*MORVS · CC0 1.0*